InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
T+90 hit rate
25%
T+90 mean return
-6.0%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by LaBarre Michael J., Chief Technology Officer. Officer active across 1 company, notably Halozyme Therapeutics, INC.. Aggregated, 46 reports have been published. Split: 0 buy · 7 sells. Total volume traded: €2.7m. History available since 3 May 2021. The latest transaction was disclosed on 25 February 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations46 total
9,300 shares@ US$58.0077.8% of flowCommon StockSEC:0001415889-25-005899:0
4,747 shares0Common StockSEC:0001415889-25-005311:0
3,386 shares0Common StockSEC:0001415889-25-004509:0
5,509 shares@ US$16.651.3% of flowCommon StockSEC:0001415889-24-025233:0
10,000 shares@ US$16.652.3% of flowCommon StockSEC:0001415889-24-023657:0
5,580 shares@ US$18.411.4% of flowCommon StockSEC:0001415889-24-022363:0
10,000 shares@ US$16.652.2% of flowCommon StockSEC:0001415889-24-021850:0
10,000 shares@ US$8.111.1% of flowCommon StockSEC:0001415889-24-020055:0
10,000 shares@ US$8.111.1% of flowCommon StockSEC:0001415889-24-017625:0
10,000 shares@ US$8.111.1% of flowCommon StockSEC:0001415889-24-014123:0
10,000 shares@ US$8.111.1% of flowCommon StockSEC:0001415889-24-011058:0
8,436 shares@ US$12.071.4% of flowCommon StockSEC:0001415889-24-009158:0
10,000 shares@ US$12.071.7% of flowCommon StockSEC:0001415889-24-007825:0
10,000 shares@ US$39.9465.5% of flowCommon StockSEC:0001415889-24-005756:0
6,112 shares0Common StockSEC:0001415889-24-004477:0
3,386 shares0Common StockSEC:0001415889-24-004187:0
8,133 shares0Common StockSEC:0001415889-24-003529:0
10,000 shares@ US$12.071.7% of flowCommon StockSEC:0001415889-24-001520:0
8,533 shares@ US$13.811.6% of flowCommon StockSEC:0001415889-23-016423:0
8,292 shares@ US$13.811.6% of flowCommon StockSEC:0001415889-23-015195:0
10,000 shares@ US$19.982.8% of flowCommon StockSEC:0001415889-23-014366:0
10,000 shares@ US$19.984.1% of flowCommon StockSEC:0001415889-23-013397:0
1,925 shares@ US$18.410.5% of flowCommon StockSEC:0001415889-23-012570:0
10,000 shares@ US$18.412.5% of flowCommon StockSEC:0001415889-23-011318:0
10,000 shares@ US$18.412.5% of flowCommon StockSEC:0001415889-23-010180:0
25 of 46 declarations
About LaBarre Michael J.
Michael J. LaBarre serves as Senior Vice President and Chief Technical Officer at Halozyme Therapeutics, Inc. In this role, he oversees the company's technological development and innovation initiatives. Michael plays a key role in improving products and processes, thereby contributing to Halozyme's growth. His expertise in biotechnology and product development enables him to effectively lead the company toward new opportunities.
